1. P87 Mesenchymal splice isoform fibroblast growth factor receptor (FGFR2c) is an independent prognostic biomarker and further refines risk stratification within endometrial cancer molecular subtypes. (1st November 2019) Authors: Sengal, A; Williams, E; McAlpine, J; Pollock, P Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗